Increasing Prevalence Of Neurological Disorders Driving Growth In The Market Due To Advancements In Diagnosis And Neural Repair Therapies Is Supporting Development Across The Nerve Growth Factor Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The Nerve Growth Factor Market In 2026 And How Much Will It Reach By 2030?

The nerve growth factor market has experienced substantial growth over recent years. Its size is projected to increase from $1.19 billion in 2025 to $1.28 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.6%. The historical growth trajectory is primarily due to advancements in neurobiology research, the clinical progression of cenegermin, the rising incidence of neurological disorders, the broader acceptance of ophthalmology treatments, and an expansion in biologics manufacturing.

The nerve growth factor market is projected for significant expansion in the coming years, with an anticipated rise to $1.71 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.6%. This growth during the forecast period is attributable to factors such as the increasing incidence of neurodegenerative diseases, the broadening of regenerative medicine programs, a surge in clinical trials for nerve repair, an increase in biologics research and development funding, and innovations in nerve growth factor delivery systems. Major trends expected in this period include expanding research in neuroregeneration therapies, an escalating focus on treating neurodegenerative diseases, the wider application of recombinant protein therapeutics, increasing clinical usage in ophthalmic disorders, and enhanced investment in nerve repair technologies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22070&type=smp

What Are The Main Drivers Accelerating The Growth Of The Nerve Growth Factor Market?

The expanding occurrence of neurological conditions is anticipated to fuel the future expansion of the nerve growth factor market. These disorders encompass medical ailments impacting the brain, spinal cord, and nerves, stemming from structural, biochemical, or electrical irregularities. The rise in neurological disorder prevalence is attributed to an aging global populace and improvements in diagnostic methods. Enhanced diagnostic technology facilitates better identification and reporting of these conditions, resulting in elevated documented incidence figures. Nerve growth factor (NGF) is vital for the upkeep, survival, and regeneration of neurons, thereby serving as an essential element in managing the incidence of neurological disorders through fostering neural repair and potentially impeding disease advancement. As an illustration, in September 2024, the Australian Institute of Health and Welfare, an Australian government body, indicated that dementia (a neurological condition) cases in Australia are forecast to increase from approximately 411,100 in 2023 to 849,300 by 2058. Consequently, the growing incidence of neurological disorders is propelling the expansion of the nerve growth factor market.

Which Segment Divisions Form The Structure Of The Nerve Growth Factor Market?

The nerve growth factor market covered in this report is segmented –

1) By Type: Alpha-Nerve Growth Factor (NGF), Beta-Nerve Growth Factor (NGF), Gamma-Nerve Growth Factor (NGF), Other Types

2) By Agents: Cenegermin, Other Agents

3) By Indication: Neurodegenerative Disorders, Spinal Cord Injuries, Eye Disorders, Epithelial Diseases, Tissue Healing, Other Indications

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Alpha-Nerve Growth Factor (α-NGF): Natural Alpha-NGF, Recombinant Alpha-NGF, Synthetic Alpha-NGF, Alpha-NGF For Research Applications

2) By Beta-Nerve Growth Factor (β-NGF): Human Beta-NGF, Animal-Derived Beta-NGF, Recombinant Beta-NGF, Therapeutic Beta-NGF, Research-Grade Beta-NGF

3) By Gamma-Nerve Growth Factor (γ-NGF): Natural Gamma-NGF, Recombinant Gamma-NGF, Synthetic Gamma-NGF, Gamma-NGF for Neurodegenerative Research

4) By Other Types: Hybrid NGF Molecules, NGF Mimetics, NGF Gene Therapy-Based Products, NGF-Infused Biomaterials

What Trends Are Influencing The Nerve Growth Factor Market?

Leading companies operating within the nerve growth factor market are concentrating their efforts on creating NGF-targeting biologic therapies, including anti-NGF monoclonal antibodies, intended to suppress NGF activity and alleviate chronic pain. An anti-NGF monoclonal antibody functions by attaching to nerve growth factor, thereby stopping it from activating its receptors, which aids in decreasing pain signaling and inflammatory responses in patients affected by degenerative or neuropathic conditions. As an illustration, in May 2023, Jiangsu Hengrui Pharmaceuticals, a China-based biopharmaceutical company, unveiled SHR-1314, an advanced anti-NGF monoclonal antibody registered for clinical assessment in individuals experiencing osteoarthritis-related pain. This treatment exhibits a highly selective binding profile that reduces NGF-mediated sensitization and a prolonged serum half-life that allows for less frequent dosing, aiming to deliver sustained pain reduction for those with chronic joint disease.

Which Industry Players Are Present In The Nerve Growth Factor Market?

Major companies operating in the nerve growth factor market are Dompé farmaceutici S.p.A., Regeneron Pharmaceuticals Inc., Mimetogen Pharmaceuticals, MimeTech Srl, Herantis Pharma, PainCeptor Pharma, Beike Biotechnology, Akeso Inc., Promega Corporation, Enzo Life Sciences Inc., Alomone Labs, Prospec-Tany Technogene Ltd., CUSABIO Technology LLC, Genexis Biotech Pvt. Ltd., Staidson Beijing BioPharmaceuticals, Biomol GmbH, Sino Biological Inc., PeproTech Inc., Abcam plc, Creative BioMart Inc.

Access The Complete Nerve Growth Factor Market Report:

https://www.thebusinessresearchcompany.com/report/nerve-growth-factor-global-market-report

Which Region Is The Primary Market For The Nerve Growth Factor Market?

Asia-Pacific was the largest region in the nerve growth factor market in 2025. The regions covered in the nerve growth factor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Nerve Growth Factor Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=22070&type=smp

Browse Through More Reports Similar to the Global Nerve Growth Factor Market 2026, By The Business Research Company

Nerve Repair And Regenerative Market Report 2026

https://www.thebusinessresearchcompany.com/report/nerve-repair-and-regenerative-global-market-report

Neuromodulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

Peripheral Nerve Injuries Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-nerve-injuries-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795